1 Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), National Institute of Health and Medical Research (INSERM) U1291, CNRS U5051, Université de Toulouse III, Toulouse, France.
2 Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
3 Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany.